cercarialdermatitis
553
cerebralschistosomo-
sis 553
hepatosplenicform
553
intestinalschistoso-
mosis 553
pulmonaryschistoso-
mosis 553
urinaryschistosomo-
sis 552
control 554
diagnosis 55 4,623, 625
cutaneousinfection
652
gastrointestinaltract
640 , 643
respiratorytract 634
urogenitaltract 636
distribution 547
epidemiology 551
haematobium 54 3,546,
54 8, 551 – 553
diagnosis 636
immunity 553 – 554
intercalatum 547 , 54 8,
551
japonicum 546 – 547 ,
54 8, 551 , 553
lifecycle 549 – 551
migrationinhuman
body 551
mansoni543,546, 54 8,
550, 551 ,553, 643
mekongi 547 , 54 8, 551 ,
553
morphology 547 – 548
occurrence 546 – 547
pathogenesis 551 – 552
acutephase 551
chronicphase
551 – 552
penetrationphase 551
prevention 554
spindale 553
therapy 554
Schizopyrenidea 477
Scleritis 655
Scopulariopsis 369
Scrapie 473
Secernentia 545
Secondarylymphoidorgan
chemokine(SLC) 83
Secretionsystemproteins
151
Secretorypiece 143
Selectins 84
Selection
antibioticresistance
201 – 202
clonalselectiontheory
67
Tcellmaturation46,
63 – 64
Sennetsufever 333
Sensitivity 209
Sensorproteins 151
Sepsis 1 0,253, 29 6, 334
E.coli 293
meningococcal 27 6, 277
nosocomialinfections
344
Septicarthritis 654
Serodiagnosis405, 411 ,
623
Serratia223, 280
marcescens 295
nosocomialinfection
343
Serumresistance 1 3, 282
Serumsickness 11 3, 143
Sesquiterpenelactones
533
Severeacuterespiratory
syndrome(SARS) 4 46,
447 – 448
diagnosis 634
Severecombinedimmu-
nodeficiencydisease
(SCID) 143
Sexuallytransmitteddis-
easesseespecificdiseases
Shellvialassay 408
Shigaliketoxins 28 8, 294
Shigatoxin 288
Shigella280, 287 – 289
boydii223, 287
classification 287 – 288
clinicalpicture 288
diagnosis 28 8, 638
dysenteriae223, 287
epidemiology 288 – 289
flexneri223, 287
pathogenesis 288
sonnei223, 287
Shingles 422
seealsoVaricella-zoster
virus(VZV)
Shutoffphenomena 393
Siderophores 13
Sigmafactors 16 8, 17 0, 181
Signalproteins 151
Simplexvirus 382
Sindbisvirus 441
Sinusitis365, 630Siphonaptera 60 6,
618 – 620
clinicalmanifestations
61 9, 620
control 619
diagnosis 61 9, 620
epidemiology 619
lifecycle 618 – 619
morphology 61 8, 619
occurrence 618
prevention 620
therapy 620
Sisomicin 189
Site-specificrecombina-
tion 17 2, 181
SkininfectionsseeCuta-
neousinfections
Skinsnip 624
Skin-associatedlymphoid
tissue(SALT) 48
Slappedcheeksyndrome
41 2–4 13
Sleepingsickness 48 3,
485 – 491
clinicalmanifestations
488 – 489
diagnosis 4 90, 625
distribution 485
epidemiology 488
prevention 490 – 491
therapy 490
seealsoTrypanosoma
brucei
Small,round-structured
viruses(SRSV)439, 440
Smallpox426, 427 , 428
diagnosis 650
eradication 427
infection/immunere-
sponserelationship 104
Sodoku 648
Somaticmutation 144
Somaticrecombination
144
SoorseeCandida
Sourcesofinfection 30
nosocomialinfections
345
SouthAmericanblasto-
mycosis354, 361
diagnosis 361
therapy 361
Sparfloxacin 189
Specificity 209
Spectinomycin 189
Spirilla 149
Spirillumminus 308
diagnosis 648SpirillumminusS 691All rights reserved. Usage subject to terms and conditions of licenseKayser, Medical Microbiology © 2005 Thieme
All rights reserved. Usage subject to terms and conditions of license.